Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Dyslipidemia Guidelines and their Impact on Clinical Decisions


Comparing the 2013 ACC/AHA & 2014 NLA Dyslipidemia Guidelines and their Impact on Clinical Decision Making

UAN: 0100-0000-15-043-H04-P/T

 

Upon completion of this knowledge-based activity, Pharmacists will be able to:

1. Identify the major differences in treatment recommendations for dyslipidemia between the 2013 ACC/AHA Guidelines and the new 2014 NLA Recommendations for Dyslipidemia.
2. List the classifications of lipoprotein lipid levels in adults.
3. Accurately identify targets for intervention in the treatment of dyslipidemia.
4. Assess a patient??s ASCVD risk and the treatment goals based on risk category.
5. Discuss lifestyle and drug therapies recommended to reduce morbidity and mortality in patients with dyslipidemia.
6. Apply NLA guidelines to formulate and evaluate initial or existing therapy to specific patient cases.
 
Upon completion of this knowledge-based activity, Pharmacy Technicians will be able to:
1. Identify the major differences in treatment recommendations for dyslipidemia between the 2013 ACC/AHA Guidelines and the new 2014 NLA Recommendations for Dyslipidemia.
2. List the classifications of lipoprotein lipid levels in adults.
3. Learn how the pharmacist can use NCA guidelines and the ASCUD risk to assess and evaluate patients.

Program Fees:

  • This webinar is FREE for AzPA Members.  Non-members pay $10.  

Continuing Education Information:

  • This knowledge-based activity has been approved for 1.0 contact hour (0.1 CEUs) of Continuing Pharmacy Education Credit by the Accreditation Council Pharmacy Education.
  • ACPE UAN: 0100-0000-15-043-H04-P/T
  • Initial Release Date: 05/04/2015
  • Planned Expiration Date: 05/04/2018

Refund Policy:

No refunds will be issued once the program has been signed up for due to the nature of the program. AzPA reserves the right to cancel any activity due to insufficient pre-registration or as determined by the Executive Director or Operations Director. In this case, all individuals pre-registered are notified and issued a full refund. Registration fees cannot be re-allocated due to the multiple steps involved with processing CE Credits.

Technology Requirements: 

It is the responsibility of the participant to ensure compatible technology is used. Please Click Here to review technical system requirements needed. 

CE Hours

1.00

CE Units

0.100

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
The Arizona Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as providers of continuing education.

Requirements for CE Credit

This knowledge-based activity has been approved for 1.0 contact hour (0.1 CEUs) of Continuing Pharmacy Education Credit by the Accreditation Council Pharmacy Education. All continuing pharmacy education credits awarded by the Arizona Pharmacy Association will be uploaded within 60 days of the completion of the activity.  Please monitor your NABP eProfile account for accuracy.  If you have any questions or identify an inaccuracy, please contact us at education@azpharmacy.org or 480-838-3385. 
 
 

 

 

 

Activity Number

0100-0000-15-043-H04-P/T

Release Date: May 4, 2015
Credit Expiration Date: May 4, 2018

CE Hours

1.00